Sarah A. Lewin

2.4k total citations · 1 hit paper
18 papers, 2.0k citations indexed

About

Sarah A. Lewin is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sarah A. Lewin has authored 18 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Sarah A. Lewin's work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Chemokine receptors and signaling (3 papers). Sarah A. Lewin is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Chemokine receptors and signaling (3 papers). Sarah A. Lewin collaborates with scholars based in United States, Germany and Ireland. Sarah A. Lewin's co-authors include David Mooney, Glenn Dranoff, Caroline S. Verbeke, Aileen W. Li, Sandeep T. Koshy, Omar A. Ali, Thomas C. Ferrante, Jaeyun Kim, Young‐Jin Choi and R. Warren Sands and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Sarah A. Lewin

18 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy

2014 457 citations Jaeyun Kim, Aileen W. Li et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Sarah A. Lewin

Since Specialization

Citations

This map shows the geographic impact of Sarah A. Lewin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Lewin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Lewin more than expected).

Fields of papers citing papers by Sarah A. Lewin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Lewin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Lewin. The network helps show where Sarah A. Lewin may publish in the future.

Co-authorship network of co-authors of Sarah A. Lewin

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Lewin. A scholar is included among the top collaborators of Sarah A. Lewin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Lewin. Sarah A. Lewin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Multicomponent Injectable Hydrogels for Antigen‐Specific Tolerogenic Immune Modulation 2017 ·Advanced Healthcare Materials ·Caroline S. Verbeke, Susana Gordo, David Schubert, Sarah A. Lewin, Rajiv M. Desai, Jessica Dobbins, Kai W. Wucherpfennig, David Mooney	85
2	Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication 2016 ·Cancer Immunology Research ·Omar A. Ali, Sarah A. Lewin, Glenn Dranoff, David Mooney	124
3	Click‐Crosslinked Injectable Gelatin Hydrogels 2016 ·Advanced Healthcare Materials ·Sandeep T. Koshy, Rajiv M. Desai, Pascal Joly, Jianyu Li, (unknown), Sarah A. Lewin, Neel Joshi, David Mooney	142
4	Injectable cryogel-based whole-cell cancer vaccines 2015 ·Nature Communications ·Sidi A. Bencherif, R. Warren Sands, Omar A. Ali, Aileen W. Li, Sarah A. Lewin, Thomas Braschler, Ting‐Yu Shih, Caroline S. Verbeke, Deen Bhatta, Glenn Dranoff, David Mooney	349
5	Black Hole: How an Idea Abandoned by Newtonians, Hated by Einstein, and Gambled on by Hawking Became Loved 2015 ·Scientific American ·Sarah A. Lewin	2
6	Identification of Immune Factors Regulating Antitumor Immunity Using Polymeric Vaccines with Multiple Adjuvants 2014 ·Cancer Research ·Omar A. Ali, Caroline S. Verbeke, Chris Johnson, R. Warren Sands, Sarah A. Lewin, (unknown), Edward J. Doherty, Glenn Dranoff, David Mooney	78
7	Local Delivery of VEGF and SDF Enhances Endothelial Progenitor Cell Recruitment and Resultant Recovery from Ischemia 2014 ·Tissue Engineering Part A ·Erin M. Anderson, Brian J. Kwee, Sarah A. Lewin, Theresa M. Raimondo, Manav Mehta, David Mooney	44
8	Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy breakdown → 2014 ·Nature Biotechnology ·Jaeyun Kim, Aileen W. Li, Young‐Jin Choi, Sarah A. Lewin, Caroline S. Verbeke, Glenn Dranoff, David Mooney	457
9	Refilling drug delivery depots through the blood 2014 ·Proceedings of the National Academy of Sciences ·Yevgeny Brudno, Eduardo A. Silva, Cathal J. Kearney, Sarah A. Lewin, A. B. Miller, (unknown), Michael Aizenberg, David Mooney	78
10	Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart 2014 ·Biomaterials ·Ellen T. Roche, Conn L. Hastings, Sarah A. Lewin, Dmitry Shvartsman, Yevgeny Brudno, Nikolay V. Vasilyev, Fergal J. O’Brien, Conor J. Walsh, Garry P. Duffy, David Mooney	128
11	Injectable, porous, and cell-responsive gelatin cryogels 2013 ·Biomaterials ·Sandeep T. Koshy, Thomas C. Ferrante, Sarah A. Lewin, David Mooney	274
12	Inflammatory Cytokines Presented from Polymer Matrices Differentially Generate and Activate DCs In Situ 2013 ·Advanced Functional Materials ·Omar A. Ali, Prakriti Tayalia, Dmitry Shvartsman, Sarah A. Lewin, David Mooney	56
13	Immunologically active cryogels for breast cancer therapy (P4329) 2013 ·The Journal of Immunology ·Sidi A. Bencherif, Dobrin Draganov, Sarah A. Lewin, Aileen W. Li, Roger Sands, Caroline S. Verbeke, Glenn Dranoff, David Mooney	2
14	In vivo imaging of ligand receptor binding with Gaussia luciferase complementation 2011 ·Nature Medicine ·Gary D. Luker, Laura Anne Mihalko, Bradley T. Schmidt, Sarah A. Lewin, Paramita Ray, Dmitry Shcherbo, Dmitriy M. Chudakov	59
15	Noninvasive Imaging Reveals Inhibition of Ovarian Cancer by Targeting CXCL12-CXCR4 2011 ·Neoplasia ·Paramita Ray, Sarah A. Lewin, Laura Anne Mihalko, Bradley T. Schmidt, Gary D. Luker	30
16	Secreted CXCL12 (SDF-1) forms dimers under physiological conditions 2011 ·Biochemical Journal ·Paramita Ray, Sarah A. Lewin, Laura Anne Mihalko, (unknown), Shuichi Takayama, Kathryn E. Luker, Gary D. Luker	50
17	Resident Workload, Pager Communications, and Quality of Care 2010 ·World Journal of Surgery ·Shaun P. Patel, Jay Lee, David N. Ranney, Shaza N. Al‐Holou, (unknown), (unknown), Sarah A. Lewin, Erqi Liu, Arin L. Madenci, (unknown), (unknown), (unknown), (unknown), David Wilkinson, Brandon M. Wojcik, Michael J. Englesbe, Raymond Lynch	31
18	Effects of Smoking on Survival for Patients with End-Stage Liver Disease 2009 ·Journal of the American College of Surgeons ·(unknown), Amit K. Mathur, William B. Acker, Shaza N. Al‐Holou, Lauren K. Ehrlichman, Sarah A. Lewin, (unknown), (unknown), David N. Ranney, (unknown), James Kubus, Michael J. Englesbe	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact